Evolutionary analysis of human immunodeficiency virus type 1 therapies based on conditionally replicating vectors.
Efforts to reduce the viral load of human immunodeficiency virus type 1 (HIV-1) during long-term treatment are challenged by the evolution of anti-viral resistance mutants. Recent studies have shown that gene therapy approaches based on conditionally replicating vectors (CRVs) could have many advant...
Enregistré dans:
Auteurs principaux: | Ruian Ke, James O Lloyd-Smith |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Public Library of Science (PLoS)
2012
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/8a34b565a0fb4c28b7d77b569d94daaa |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Human Immunodeficiency Virus Type 2: The Neglected Threat
par: Giancarlo Ceccarelli, et autres
Publié: (2021) -
Human APOBEC3 induced mutation of human immunodeficiency virus type-1 contributes to adaptation and evolution in natural infection.
par: Eun-Young Kim, et autres
Publié: (2014) -
Clinical use of cobicistat as a pharmacoenhancer of human immunodeficiency virus therapy
par: von Hentig N
Publié: (2015) -
In vivo Serial Passaging of Human–Simian Immunodeficiency Virus Clones Identifies Characteristics for Persistent Viral Replication
par: Rajesh Thippeshappa, et autres
Publié: (2021) -
Assessment of oral health and prevalence of oral conditions in human immunodeficiency virus-infected subjects visiting antiretroviral therapy centers
par: Wagisha Barbi, et autres
Publié: (2021)